Responsible AI Governance: Model Selection, Monitoring and Bias

The models inside a clinical tool are not interchangeable commodities. Which model you use, how you monitor it, and how you watch for systematic bias are governance decisions with direct safety consequences — and they deserve the same rigour as any other clinical-risk control.

Model selection as a safety decision

Responsible selection weighs more than raw benchmark scores. It considers the provider’s terms of service (and whether they permit clinical use at all), data-handling commitments, jurisdiction, and stability. A model that is marginally more accurate but whose licence forbids medical use is not a candidate — it is excluded.

Continuous monitoring

• Benchmarking against curated cases: a held-out set of representative appointments is used to score quality before any change ships, so regressions are caught before clinicians are.
• Edit-pattern analysis: what clinicians change most often points to where the system is weakest.
• Error monitoring and alerting: failures in production are tracked and triaged rather than quietly retried.

Bias and equity

Speech systems can perform unevenly across accents and dialects, and clinical models can carry the biases of their training data. Taking this seriously means testing across the range of voices a tool will actually meet and treating uneven performance as a defect to fix, not a quirk to tolerate. Governance is what turns these good intentions into a repeatable process.